FDA Import Refusal 799-9138282-3/10003/1 — Abbvie Corporation
The FDA refused shipment 799-9138282-3/10003/1 from Abbvie Corporation (Canada) on Nov 19, 2025. The refused product falls under Drugs and Biologics — UPADACITINIB (ANTI-RHEUMATIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 19, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62QCA06 UPADACITINIB (ANTI-RHEUMATIC)
- Charges
- 75